The combination of thalidomide and intermediate-dose dexamethasone is an effective but toxic treatment for patients with primary amyloidosis (AL)
Year: 2004
Type: article
Study design: Clinical Trial
Source: Blood
Language: English
Subfield: Internal Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2041167176
